D'ANIELLO, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 127
EU - Europa 72
AS - Asia 60
AF - Africa 6
SA - Sud America 3
Totale 268
Nazione #
US - Stati Uniti d'America 126
SG - Singapore 25
IT - Italia 24
CN - Cina 17
HK - Hong Kong 14
NL - Olanda 12
FI - Finlandia 10
DE - Germania 9
CI - Costa d'Avorio 6
RU - Federazione Russa 6
FR - Francia 4
IE - Irlanda 4
IN - India 3
BE - Belgio 2
BR - Brasile 2
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CA - Canada 1
Totale 268
Città #
Chandler 20
Singapore 15
Ashburn 14
Hong Kong 14
Amsterdam 12
Napoli 12
Santa Clara 9
Naples 8
Beijing 7
Helsinki 6
Millbury 6
Princeton 6
Munich 4
Nanjing 4
Seattle 4
Boston 3
Shenyang 3
Boardman 2
Courcelles 2
Dallas 2
Des Moines 2
Dublin 2
Falls Church 2
Nuremberg 2
Pune 2
Washington 2
Wilmington 2
Ann Arbor 1
Bandar Seri Begawan 1
Changsha 1
Concordia 1
Darmstadt 1
Falkenstein 1
Hangzhou 1
Houston 1
Jacksonville 1
Kronberg 1
Kunming 1
Los Angeles 1
Moscow 1
Mumbai 1
New York 1
Orindiúva 1
Ottawa 1
Palma Campania 1
Rio de Janeiro 1
Sofia 1
Totale 187
Nome #
A third-line sorafenib aftrer sequential therapy with sunitinib and mTOR inhibitors in methastatic renal cell carcinoma 54
Exploring the molecular aspects associated with testicular germ cell tumors: A review 51
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 50
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 47
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 42
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 34
Totale 278
Categoria #
all - tutte 1.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 4 5 0
2020/20216 0 0 2 0 3 0 0 0 0 0 1 0
2021/202240 0 0 0 0 1 0 0 1 2 6 16 14
2022/202355 6 2 1 3 9 7 0 4 6 13 4 0
2023/202455 1 3 10 7 2 12 0 10 0 1 4 5
2024/202572 7 2 0 7 7 10 25 14 0 0 0 0
Totale 278